Lang Walker reckons he is yet to have his greatest success investing in biotechnology companies, but he has no problem identifying his biggest failure: the $10 million he lost backing a novel pain-relief drug.
Jessica Gardner is Deputy editor - News. She has previously edited the Companies and Markets section. Connect with Jessica on Twitter. Email Jessica at jgardner@afr.com
